Diabetes & Nephrology News, Research Studies | Clinical Treatment Articles

Diabetes

DIABETES

Canagliflozin Protects Against Renal Function Decline in Advanced Diabetic CKD

WASHINGTON—Canagliflozin showed a protective effect against kidney function decline in patients with type 2 diabetes and a baseline estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m2, new study findings presented at the American Society of Nephrology’s Kidney Week 2019 meeting suggest. The findings are from a post-hoc subgroup analysis of the phase 3 CREDENCE…
Next post in Diabetes